Skip to Content

Join the 'Lung Cancer' group to help and get support from people like you.

Lung Cancer News

Related terms: Cancer, Bronchogenic Carcinoma, Cancer, Lung

Best Ways to Quit Smoking, Cut Your Lung Cancer Risk

Posted 15 days ago by Drugs.com

FRIDAY, Jan. 5, 2018 – While there is no sure way to avoid lung cancer, there are steps you can take to reduce your risk. Smoking contributes to 80 to 90 percent of lung cancer deaths, according to the American Lung Association. Men who smoke have a 23 times increased risk of lung cancer. And exposure to secondhand smoke causes approximately 7,330 lung cancer deaths among nonsmokers in the United States every year. So, if you've never smoked, don't start. If you do smoke, try to quit. Talk to your doctor about methods and aids to help you quit. These include nicotine replacement products, medications and support groups, according to UPMC Pinnacle, part of the University of Pittsburgh Medical Center health care system. To boost your stop-smoking resolve, the health care system recommends the following steps: Set a quit date to solidify your commitment to quitting. Make it a significant ... Read more

Related support groups: Smoking, Smoking Cessation, Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Bronchogenic Carcinoma

High Costs Keep Many Cancer Patients From Needed Drugs

Posted 21 Dec 2017 by Drugs.com

THURSDAY, Dec. 21, 2017 – Cancer drugs have become so pricey that U.S. patients often can't afford them, a new study finds. The findings suggest that high out-of-pocket costs may be a barrier to potentially life-saving or life-prolonging treatments, the researchers said, and raise questions about whether patients will be able to take advantage of new cancer treatments. "Imagine leaving your doctor's office with a plan, ready to start treatment, only to find you can't afford it," said study author Jalpa Doshi, from the University of Pennsylvania School of Medicine. "It adds more stress at what is already a stressful and scary time," she said in a UPenn news release. Doshi is a professor of general internal medicine at Penn and director of value-based insurance design initiatives at the university's Center for Health Incentives and Behavioral Economics. The study involved more than ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Melanoma

New Trial Cancer Drug, Ulixertinib, Shows Promise Against Wide Range of Tumors

Posted 15 Dec 2017 by Drugs.com

FRIDAY, Dec. 15, 2017 – A new drug that targets a genetic flaw common to most cancer cells is showing potency against many tumor types. The preliminary trial of a drug called ulixertinib was conducted with 135 patients who had already failed treatments for one of a variety of advanced, solid tumors. Researchers led by Dr. Ryan Sullivan, of Massachusetts General Hospital, said ulixertinib did seem to spur at least a "partial response" to the therapy or "disease stabilization," regardless of cancer type. "It was exciting to see responses in some patients," said Sullivan, an oncologist and member of the Termeer Center for Targeted Therapies at the Boston hospital. "The results of this study can be built upon to develop better treatment regimens for these patients," he said in a news release from the American Association for Cancer Research (AACR). One cancer specialist explained how ... Read more

Related support groups: Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Ovarian Cancer, Solid Tumors

Local Smoke-Free Laws Tied to Fewer Lung Cancer Cases

Posted 5 Dec 2017 by Drugs.com

TUESDAY, Dec. 5, 2017 – Communities with strong smoke-free workplace laws have lower lung cancer rates than those with no smoke-free laws, researchers report. The new study was conducted in Kentucky, which has one of the highest lung cancer rates in the United States. University of Kentucky researchers examined 20 years of data on new lung cancer cases among state residents aged 50 and older. The investigators then looked to see whether those with lung cancer lived in communities with strong, moderate or weak smoke-free laws. The lung cancer rate was 8 percent lower in communities with strong smoke-free workplace laws than in communities without smoke-free laws, the findings showed. There were no differences in lung cancer rates between communities with moderate or weak smoking laws and those with no such laws. "Kentucky has one of the highest adult cigarette smoking rates and the ... Read more

Related support groups: Smoking, Smoking Cessation, Lung Cancer, Non-Small Cell Lung Cancer

Insurance Ups the Odds of Beating Cancer

Posted 5 Dec 2017 by Drugs.com

TUESDAY, Dec. 5, 2017 – Your chances of surviving cancer may depend on the type of insurance you have. Researchers from the Cancer Prevention Institute of California found significant improvements in survival among cancer patients with private insurance or Medicare, but not among those who have public insurance such as Medicaid, or are uninsured. The investigators analyzed data on more than 1.1 million patients in California diagnosed with the five most common types cancer in the state – breast, colon, lung, melanoma and prostate – between 1997 and 2014. Compared with people who had private insurance, those who had no insurance had a much higher death rate for all cancers except prostate. Those with Medicaid had a much higher death rate for all cancer types except lung cancer, the researchers found. Also, they found that Medicaid patients had higher survival rates than uninsured ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Melanoma

Lung Cancer Drug Targets 'Hidden' HIV in French Patient

Posted 1 Dec 2017 by Drugs.com

FRIDAY, Dec. 1, 2017 – In a case that investigators say is a first, a lung cancer drug unmasked and then attacked the kind of HIV-infected cells that standard antiretroviral therapy has been unable to touch. The finding was reported on Dec. 1, which is also World AIDS Day, in the Annals of Oncology. While one AIDS expert said the findings were promising, she noted the drug did not "cure" the patient of HIV. The potential breakthrough centers on the experience of a single 51-year-old French man, who has been receiving treatment in Paris for advanced-stage non-small cell lung cancer for the past year. The patient – who is also HIV-positive – had undergone both surgery and chemotherapy for tumors that had initially been diagnosed in 2015, before he experienced a relapse in 2016. So, French clinicians gave him the cancer treatment nivolumab (Opdivo). The drug is commonly used for ... Read more

Related support groups: HIV Infection, Lung Cancer, Non-Small Cell Lung Cancer, Opdivo, Nivolumab

Commitment Is Key for Online Quit-Smoking Groups

Posted 13 Nov 2017 by Drugs.com

MONDAY, Nov. 13, 2017 – An online social network designed to help you quit smoking can do just that, a new study finds. But the odds of quitting rise along with the level of active involvement, the researchers said. They examined the impact of BecomeAnEX.org, a social network site created by the nonprofit anti-tobacco group Truth Initiative, in collaboration with the Mayo Clinic. Network users can share information and support through blogs, forums and messages. More than 800,000 people have registered since the network was launched in 2008. The study included more than 2,600 smokers who signed up on BecomeAnEX.org. After three months, 21 percent of those who actively contributed content on the site had quit smoking, compared with 11 percent who only read others' posts and 8 percent of those who never visited the site. Researchers from the Truth Initiative and the University of Iowa ... Read more

Related support groups: Smoking, Smoking Cessation, Nicotine, Lung Cancer, Non-Small Cell Lung Cancer, Nicorette, Nicoderm CQ, Small Cell Lung Cancer, Nicotrol Inhaler, Commit, Habitrol, Bronchogenic Carcinoma, ProStep, Nicotrol TD, Nicorelief, Nicorette DS, Nicotrol NS

FDA Approves Alecensa (alectinib) as First-Line Treatment for ALK-Positive Metastatic Non-Small Cell Lung Cancer

Posted 13 Nov 2017 by Drugs.com

South San Francisco, CA – November 6, 2017 - Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Alecensa (alectinib) for the treatment of people with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test. The approval is based on results from the Phase III ALEX study, which showed Alecensa significantly reduced the risk of disease worsening or death (progression-free survival, PFS) by 47 percent (HR=0.53, 95 percent CI: 0.38, 0.73, p Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Alectinib, Alecensa

Yoga May Give Lung Cancer Patients, Caregivers a Boost

Posted 7 Nov 2017 by Drugs.com

TUESDAY, Nov. 7, 2017 – For advanced lung cancer patients, yoga appears to help improve their overall physical function, stamina and mental health. And it appears to give their caregivers a boost, as well. The findings stem from a small study of 26 patients and caregivers. The study participants, most of whom were in their 60s, took part in an average of 12 yoga sessions. The focus was on breathing exercises, physical postures and meditation. "It is never too late to engage in exercise, and we know from earlier studies that people can exercise while being treated with chemotherapy or radiation," said study lead author Kathrin Milbury. "Caregivers sometimes have more anxiety and sleeping problems than patients. Therefore, we thought that having the patient and caregiver go through yoga instruction together would be beneficial for both partners," she explained. Milbury is an assistant ... Read more

Related support groups: Anxiety and Stress, Cancer, Lung Cancer, History - Radiation Therapy

Yoga May Give Lung Cancer Patients, Caregivers a Boost

Posted 7 Nov 2017 by Drugs.com

TUESDAY, Nov. 7, 2017 – For advanced lung cancer patients, yoga appears to help improve their overall physical function, stamina and mental health. And it appears to give their caregivers a boost, as well. The findings stem from a small study of 26 patients and caregivers. The study participants, most of whom were in their 60s, took part in an average of 12 yoga sessions. The focus was on breathing exercises, physical postures and meditation. "It is never too late to engage in exercise, and we know from earlier studies that people can exercise while being treated with chemotherapy or radiation," said study lead author Kathrin Milbury. "Caregivers sometimes have more anxiety and sleeping problems than patients. Therefore, we thought that having the patient and caregiver go through yoga instruction together would be beneficial for both partners," she explained. Milbury is an assistant ... Read more

Related support groups: Anxiety and Stress, Cancer, Lung Cancer, History - Radiation Therapy

Could a Common Blood Thinner Lower Cancer Risk?

Posted 7 Nov 2017 by Drugs.com

MONDAY, Nov. 6, 2017 – A pill widely taken to prevent heart attack and stroke may also guard against cancer, new research suggests. Warfarin is an inexpensive blood thinner. It's typically prescribed for patients whose leg arteries are prone to clots and for patients with the abnormal heartbeat called atrial fibrillation. Now, Norwegian investigators say it may also protect against any type of cancer and from prostate, lung and breast cancer, in particular. Lower colon cancer risk was also reported, but only in people taking warfarin for A-fib, according to the study. The findings don't prove that warfarin reduces the risk of cancer, cautioned lead researcher James Lorens. "This is an observational study using data on more than 1.25 million people 50 and older from Norwegian national registries, and cannot prove a cause-and-effect relationship," said Lorens, a professor of biomedicine ... Read more

Related support groups: Cancer, Warfarin, Atrial Fibrillation, Coumadin, Breast Cancer, Heart Attack, Prostate Cancer, Lung Cancer, Myocardial Infarction, Jantoven, Myocardial Infarction - Prophylaxis

Patients' Gut Bugs May Play Role in Cancer Care

Posted 3 Nov 2017 by Drugs.com

THURSDAY, Nov. 2, 2017 – The type of bacteria that cancer patients harbor in the gut might affect their odds of responding to certain treatments, two early studies hint. The research, in humans and mice, adds to evidence that gut bacteria play a key role in the immune system. But experts stressed it's too soon to make recommendations to cancer patients – including whether they should take "probiotic" supplements. Both studies looked at whether there's a link between patients' gut bacteria and their responses to newer cancer drugs called PD-1 inhibitors. The drugs, which include Keytruda (pembrolizumab) and Opdivo (nivolumab), work by freeing up the immune system to attack cancer cells. The drugs are approved for several cancers, including advanced cases of melanoma, lung, bladder and stomach cancers. In one study, researchers focused on 112 patients with advanced melanoma, the ... Read more

Related support groups: Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Melanoma, Keytruda, Opdivo, Bladder Cancer, Nivolumab, Pembrolizumab, Gastrinoma

Speed Up the 'Cancer Moonshot,' Doctors Urge

Posted 1 Nov 2017 by Drugs.com

TUESDAY, Oct. 31, 2017 – The Cancer Moonshot Initiative now has a detailed road map designed to cram a decade's worth of medical advancement into half that time. A new report, authored by more than 50 leading U.S. cancer doctors, highlights 13 priority areas for improving the medical response to cancer, along with measurable goals and a specific timeline for meeting each of those objectives. The plan is intended to help "accelerate existing progress so that we deliver in five years what would have historically taken 10," said Dr. Cliff Hudis, chief executive officer of the American Society of Clinical Oncology and co-author of the report. It was created by The Lancet Oncology Commission on Future Research Priorities in the USA. In late 2016, Congress appropriated $1.8 billion for cancer research funding over the next seven years for the so-called Cancer Moonshot, said commission ... Read more

Related support groups: Cancer, Methotrexate, Breast Cancer, Prostate Cancer, Fluorouracil, Lung Cancer, Gleevec, Colorectal Cancer, Non-Small Cell Lung Cancer, Melanoma, Tasigna, Xeloda, Sprycel, Herceptin, Hydroxyurea, Mercaptopurine, Cervical Cancer, Hydrea, Cisplatin, Cytoxan

Survival Odds Improving for Lung Cancer Patients

Posted 26 Oct 2017 by Drugs.com

THURSDAY, Oct. 26, 2017 – In a finding that offers some hope to those fighting lung cancer, researchers report that survival rates have improved among those with early stage disease. "More and more patients are being cured of lung cancer, with both surgery and radiation as good treatment options," said study author Dr. Nirav Kapadia, from the Dartmouth-Hitchcock Medical Center in New Hampshire. "Our study optimistically suggests that if current trends persist, survival for [non-small-cell lung cancer] will continue to improve over time," he said. The study included more than 65,000 people diagnosed with stage 1 non-small-cell lung cancer between 2000 and 2010. Of that group, 62 percent had surgery, 15 percent received radiation therapy, 3 percent had both surgery and radiation and 18 percent received neither treatment. The two-year survival rate for people treated with either surgery ... Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Bronchogenic Carcinoma

Many Cancer Patients Skimp on Treatment Due to Cost

Posted 24 Oct 2017 by Drugs.com

TUESDAY, Oct. 24, 2017 – The high cost of cancer care in the United States has led more than one-quarter of patients to cut back on some part of their treatment, a new survey reveals. Commissioned by the American Society of Clinical Oncology (ASCO), the report found that 27 percent of cancer survivors or close relatives of a cancer patient said they'd skipped doctor visits or taken other steps to reduce health costs. To save money, nearly one in 10 said they had avoided doctor appointments. Eight percent had refused treatment; postponed filling or not filled prescriptions; or skipped doses of prescribed medications. And 7 percent said they had cut pills in half, according to the survey of more than 4,000 adults. Such measures can jeopardize treatment success, ASCO says. "We should all be alarmed that Americans are potentially risking not only their health, but also their lives, due to ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Fluorouracil, Arimidex, Lupron Depot, Femara, Lung Cancer, Gleevec, Colorectal Cancer, Non-Small Cell Lung Cancer, Anastrozole, Zoladex, Votrient, Letrozole

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Bronchogenic Carcinoma, Cancer